Oral xanthine derivatives (theophylline and doxofylline) for patients with stable chronic obstructive pulmonary disease (COPD)

Olga M. García Morales; Maria Ximena Rojas-Reyes; Rodolfo J. Dennis

doi:10.1002/14651858.CD012748

Oral xanthine derivatives (theophylline and doxofylline) for patients with stable chronic obstructive pulmonary disease (COPD)

Olga M. García Morales
, Maria Ximena Rojas-Reyes
, Rodolfo J. Dennis

Research output: Contribution to Journal › Research Article › peer-review

3 Scopus citations

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compare the efficacy and safety of adding oral theophylline or doxofylline to usual treatment (long-acting beta₂-agonists, antimuscarinics, inhaled corticosteroids) versus providing usual treatment alone for patients with stable COPD.

Original language	English (US)
Article number	CD012748
Journal	Cochrane Database of Systematic Reviews
Volume	2017
Issue number	8
DOIs	https://doi.org/10.1002/14651858.CD012748
State	Published - Aug 3 2017
Externally published	Yes

All Science Journal Classification (ASJC) codes

Pharmacology (medical)

Access to Document

10.1002/14651858.CD012748

Cite this

@article{c84fb690d4c54bc6a89b5f65cfc9984e,

title = "Oral xanthine derivatives (theophylline and doxofylline) for patients with stable chronic obstructive pulmonary disease (COPD)",

abstract = "This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compare the efficacy and safety of adding oral theophylline or doxofylline to usual treatment (long-acting beta2-agonists, antimuscarinics, inhaled corticosteroids) versus providing usual treatment alone for patients with stable COPD.",

author = "\{Garc{\'i}a Morales\}, \{Olga M.\} and Rojas-Reyes, \{Maria Ximena\} and Dennis, \{Rodolfo J.\}",

note = "Funding Information: This project was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to Cochrane Airways. The views and opinions expressed therein are those of the review authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS, or the Department of Health. Publisher Copyright: {\textcopyright} 2017 The Cochrane Collaboration. Published by John Wiley \& Sons, Ltd.",

year = "2017",

month = aug,

day = "3",

doi = "10.1002/14651858.CD012748",

language = "English (US)",

volume = "2017",

journal = "Cochrane Database of Systematic Reviews",

issn = "1465-1858",

publisher = "John Wiley and Sons Ltd",

number = "8",

}

TY - JOUR

T1 - Oral xanthine derivatives (theophylline and doxofylline) for patients with stable chronic obstructive pulmonary disease (COPD)

AU - García Morales, Olga M.

AU - Rojas-Reyes, Maria Ximena

AU - Dennis, Rodolfo J.

N1 - Funding Information: This project was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to Cochrane Airways. The views and opinions expressed therein are those of the review authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS, or the Department of Health. Publisher Copyright: © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

PY - 2017/8/3

Y1 - 2017/8/3

N2 - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compare the efficacy and safety of adding oral theophylline or doxofylline to usual treatment (long-acting beta2-agonists, antimuscarinics, inhaled corticosteroids) versus providing usual treatment alone for patients with stable COPD.

AB - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compare the efficacy and safety of adding oral theophylline or doxofylline to usual treatment (long-acting beta2-agonists, antimuscarinics, inhaled corticosteroids) versus providing usual treatment alone for patients with stable COPD.

UR - https://www.scopus.com/pages/publications/85028375609

UR - https://www.scopus.com/pages/publications/85028375609#tab=citedBy

U2 - 10.1002/14651858.CD012748

DO - 10.1002/14651858.CD012748

M3 - Research Article

AN - SCOPUS:85028375609

SN - 1465-1858

VL - 2017

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 8

M1 - CD012748

ER -

Oral xanthine derivatives (theophylline and doxofylline) for patients with stable chronic obstructive pulmonary disease (COPD)

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this